Thalidomide-NH-PEG7 is a conjugate of an E3 ligase ligand and a linker, utilized in constructing PROTAC molecules such as iRucaparib-AP6 for the selective degradation of PARP1. This compound is a key reagent in chemical biology and oncology research for developing targeted protein degradation tools in both cellular and in vivo studies.
